Related references
Note: Only part of the references are listed.Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study
Norman Ilowite et al.
CLINICAL RHEUMATOLOGY (2009)
Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
Helen J. Lachmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis
Gerd Horneff et al.
RHEUMATOLOGY (2009)
Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate
Jonathan Kay et al.
ARTHRITIS AND RHEUMATISM (2008)
Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis
Daniel J. Lovell et al.
ARTHRITIS AND RHEUMATISM (2008)
Current perspectives of autologous stem cell transplantation for severe juvenile idiopathic arthritis
N. M. Wulffraat et al.
AUTOIMMUNITY (2008)
Adalimumab with or without methotrexate in juvenile rheumatoid arthritis
Daniel J. Lovell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Safety and efficacy of once-weekly application of Etanercept in children with juvenile idiopathic arthritis
Jasmin B. Kuemmerle-Deschner et al.
RHEUMATOLOGY INTERNATIONAL (2007)
A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis
Nicolino Ruperto et al.
ARTHRITIS AND RHEUMATISM (2007)
Vaccination with selected synovial T cells in rheumatoid arthritis
Guangjie Chen et al.
ARTHRITIS AND RHEUMATISM (2007)
Neonatal-onset multisystem inflammatory disease responsive to interleukin-1β inhibition
Raphaela Goldbach-Mansky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis
DJ Lovell et al.
ARTHRITIS AND RHEUMATISM (2006)
The impact of glycosylation on HLA-DR1-restricted T cell recognition of type II collagen in a mouse model
A von Delwig et al.
ARTHRITIS AND RHEUMATISM (2006)
Prevention and reversal of nephritis in MRL/lpr mice with a single injection of C-reactive protein
W Rodriguez et al.
ARTHRITIS AND RHEUMATISM (2006)
Heat-shock protein 60 as a tool for novel therapeutic strategies that target the induction of regulatory T cells in human arthritis
Sylvia Kamphuis et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2006)
Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis
S Kamphuis et al.
LANCET (2005)
Use of biologicals for treating juvenile idiopathic arthritis. Consensus statement of the 2004 Seventh Worlitzer Expert Panel for the German Juvenile Rheumatology Association
G Horneff
MONATSSCHRIFT KINDERHEILKUNDE (2005)
Leflunomide or methotrexate for juvenile rheumatoid arthritis
E Silverman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Tuberculosis in a nine-year-old girl treated with infliximab for systemic juvenile idiopathic arthritis
W Armbrust et al.
RHEUMATOLOGY (2004)
Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis
BJ Prakken et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate
N Ruperto et al.
ARTHRITIS AND RHEUMATISM (2004)
The German etanercept registry for treatment of juvenile idiopathic arthritis
G Horneff et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial
F Zulian et al.
RHEUMATOLOGY (2004)
Evidence-based treatment with methotrexate in children with rheumatic disorders.: Consensus statement of the Working Group for Children and Adolescents with Rheumatic Diseases in Germany and the Working Group on Pediatric Rheumatology in Austria
T Niehues et al.
MONATSSCHRIFT KINDERHEILKUNDE (2003)
Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type
P Quartier et al.
ARTHRITIS AND RHEUMATISM (2003)
Revised recommendations of the Deutsche Gesellschaft fur Rheumatologie on therapy with tumor necrosis factor-inhibiting active substances on inflammatory rheumatoid diseases.
B Manger
ZEITSCHRIFT FUR RHEUMATOLOGIE (2002)
A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies
R Burgos-Vargas et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
Sulphasalazine-induced systemic lupus erythematosus in a patient with ankylosing spondylitis
WC Tsai et al.
CLINICAL RHEUMATOLOGY (2002)
The efficacy and safety of intraarticular corticosteroid therapy for coxitis in juvenile rheumatoid arthritis
J Neidel et al.
ARTHRITIS AND RHEUMATISM (2002)
Etanercept in children with polyarticular juvenile rheumatoid arthritis.
DJ Lovell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
